Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Shares Issued (2022 - 2025)

Historic Shares Issued for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to $808000.0.

  • Praxis Precision Medicines' Shares Issued rose 30199.0% to $808000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year increase of 37529.41%. This contributed to the annual value of $2.6 million for FY2024, which is 53293.27% up from last year.
  • Per Praxis Precision Medicines' latest filing, its Shares Issued stood at $808000.0 for Q3 2025, which was up 30199.0% from $294000.0 recorded in Q2 2025.
  • In the past 5 years, Praxis Precision Medicines' Shares Issued registered a high of $2.0 million during Q4 2024, and its lowest value of $1000.0 during Q3 2023.
  • Over the past 4 years, Praxis Precision Medicines' median Shares Issued value was $294000.0 (recorded in 2025), while the average stood at $409133.3.
  • Per our database at Business Quant, Praxis Precision Medicines' Shares Issued tumbled by 9975.61% in 2023 and then surged by 2000000.0% in 2024.
  • Over the past 4 years, Praxis Precision Medicines' Shares Issued (Quarter) stood at $163000.0 in 2022, then tumbled by 34.97% to $106000.0 in 2023, then soared by 1762.26% to $2.0 million in 2024, then tumbled by 59.07% to $808000.0 in 2025.
  • Its last three reported values are $808000.0 in Q3 2025, $294000.0 for Q2 2025, and $560000.0 during Q1 2025.